An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15.
- Bachelerie F INSERM UMR-S996, Laboratory of Excellence in Research on Medication and Innovative Therapeutics, Université Paris-Sud, Clamart, France.
- Graham GJ Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.
- Locati M Department of Molecular Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
- Mantovani A Department of Molecular Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
- Murphy PM Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Nibbs R Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.
- Rot A Medical Research Council Centre for Immune Regulation, Institute of Biomedical Research, School of Infection and Immunity, University of Birmingham, Birmingham, UK.
- Sozzani S Istituto Clinico Humanitas, Humanitas University, Rozzano, Milano, Italy.
- Thelen M Institute for Research in Biomedicine, Bellinzona, Switzerland.
- 2015-05-12
Published in:
- British journal of pharmacology. - 2015
English
Chemokines and their receptors are essential regulators of in vivo leukocyte migration and, some years ago, a systematic nomenclature system was developed for the chemokine receptor family. Chemokine receptor biology and biochemistry was recently extensively reviewed. In this review, we also highlighted a new component to the nomenclature system that incorporates receptors previously known as 'scavenging', or 'decoy', chemokine receptors on the basis of their lack of classical signalling responses to ligand binding and their general ability to scavenge, or sequester, their cognate chemokine ligands. These molecules are now collectively referred to as 'atypical chemokine receptors', or ACKRs, and play fundamental roles in regulating in vivo responses to chemokines. This commentary highlights this new addition to the chemokine receptor nomenclature system and provides brief information on the four receptors currently covered by this nomenclature.
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.1111/bph.13182
- PMID 25958743
- Persistent URL
- https://sonar.ch/global/documents/80588
Statistics
Document views: 26
File downloads:
- Full-text: 0